Explore the full ADLM 2025 Scientific Program Online
Browse by day, topic, type, and more to discover the latest in lab medicine in ADLM 2025 Plenaries, Scientific Sessions, Roundtables, University Courses, and special events.
Tuesday, July 29
11:00 - 11:20 a.m.
Exhibit Hall Theater 3
Supported by Fortis Life
The use of isothermal amplification technology in molecular diagnostics has created a demand for warmstart modified enzymes that are inactive at ambient temperature but progressively activated as reactions are heated to temperatures above 50°C. While a variety of chemical and biological methods are available for hotstart modification of enzymes, such as DNA polymerases, these modalities typically require sustained temperatures >90°C for complete activation. Here we describe a novel workflow for the discovery, screening, and validation of recombinant camelid heavy-chain variable (VHH) domains, which can be used to warmstart modify enzymes used in isothermal amplification. As a proof-of-principle we describe the development of a novel warmstart VHH for Bst DNA polymerase that prevents off-target DNA amplification in a common LAMP assay format. This approach to enzyme warmstart modification presents a simple, yet robust, way to control reactions.
Brendan Looyenga, PhD
Principal Scientist, Fortis Life
Sam Sugerman, PhD
Principal Scientist, Fortis Life